vs
Side-by-side financial comparison of NATURES SUNSHINE PRODUCTS INC (NATR) and TOMPKINS FINANCIAL CORP (TMP). Click either name above to swap in a different company.
TOMPKINS FINANCIAL CORP is the larger business by last-quarter revenue ($194.8M vs $123.8M, roughly 1.6× NATURES SUNSHINE PRODUCTS INC). TOMPKINS FINANCIAL CORP runs the higher net margin — 49.4% vs 3.3%, a 46.1% gap on every dollar of revenue. On growth, TOMPKINS FINANCIAL CORP posted the faster year-over-year revenue change (152.7% vs 4.7%). TOMPKINS FINANCIAL CORP produced more free cash flow last quarter ($31.9M vs $7.6M). Over the past eight quarters, TOMPKINS FINANCIAL CORP's revenue compounded faster (63.6% CAGR vs 5.6%).
Nature's Sunshine Products, Inc. also known as "NSP", is a manufacturer of dietary supplements, including herbs, vitamins, minerals, and personal care products. It is based in Lehi, Utah, with a manufacturing facility in Spanish Fork, Utah.
Tompkins Financial Corporation is a small, diversified financial services company based in Ithaca, New York. It is the parent of the Tompkins Trust Company, as well as several other banks, an insurance agency, and a wealth management division.
NATR vs TMP — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $123.8M | $194.8M |
| Net Profit | $4.1M | $96.2M |
| Gross Margin | 72.5% | — |
| Operating Margin | 4.3% | 71.7% |
| Net Margin | 3.3% | 49.4% |
| Revenue YoY | 4.7% | 152.7% |
| Net Profit YoY | 1379.4% | 388.9% |
| EPS (diluted) | $0.23 | $6.72 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $123.8M | $194.8M | ||
| Q3 25 | $128.3M | $87.4M | ||
| Q2 25 | $114.8M | $82.6M | ||
| Q1 25 | $113.2M | $81.7M | ||
| Q4 24 | $118.2M | $77.1M | ||
| Q3 24 | $114.6M | $76.6M | ||
| Q2 24 | $110.6M | $72.7M | ||
| Q1 24 | $111.0M | $72.8M |
| Q4 25 | $4.1M | $96.2M | ||
| Q3 25 | $5.3M | $23.7M | ||
| Q2 25 | $5.3M | $21.5M | ||
| Q1 25 | $4.7M | $19.7M | ||
| Q4 24 | $-321.0K | $19.7M | ||
| Q3 24 | $4.3M | $18.6M | ||
| Q2 24 | $1.3M | $15.7M | ||
| Q1 24 | $2.3M | $16.9M |
| Q4 25 | 72.5% | — | ||
| Q3 25 | 73.3% | — | ||
| Q2 25 | 71.7% | — | ||
| Q1 25 | 72.1% | — | ||
| Q4 24 | 72.0% | — | ||
| Q3 24 | 71.3% | — | ||
| Q2 24 | 71.4% | — | ||
| Q1 24 | 71.2% | — |
| Q4 25 | 4.3% | 71.7% | ||
| Q3 25 | 7.0% | 35.6% | ||
| Q2 25 | 3.7% | 34.2% | ||
| Q1 25 | 5.4% | 31.6% | ||
| Q4 24 | 3.8% | 33.4% | ||
| Q3 24 | 4.6% | 32.0% | ||
| Q2 24 | 5.1% | 28.3% | ||
| Q1 24 | 4.2% | 30.4% |
| Q4 25 | 3.3% | 49.4% | ||
| Q3 25 | 4.2% | 27.1% | ||
| Q2 25 | 4.6% | 26.0% | ||
| Q1 25 | 4.2% | 24.1% | ||
| Q4 24 | -0.3% | 25.5% | ||
| Q3 24 | 3.8% | 24.3% | ||
| Q2 24 | 1.2% | 21.6% | ||
| Q1 24 | 2.1% | 23.2% |
| Q4 25 | $0.23 | $6.72 | ||
| Q3 25 | $0.30 | $1.65 | ||
| Q2 25 | $0.28 | $1.50 | ||
| Q1 25 | $0.25 | $1.37 | ||
| Q4 24 | $-0.02 | $1.39 | ||
| Q3 24 | $0.23 | $1.30 | ||
| Q2 24 | $0.07 | $1.10 | ||
| Q1 24 | $0.12 | $1.18 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $93.9M | $132.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $161.6M | $938.4M |
| Total Assets | $261.1M | $8.7B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $93.9M | $132.8M | ||
| Q3 25 | $95.6M | $193.5M | ||
| Q2 25 | $81.3M | $212.6M | ||
| Q1 25 | $86.5M | $193.1M | ||
| Q4 24 | $84.7M | $134.4M | ||
| Q3 24 | $78.7M | $132.3M | ||
| Q2 24 | $68.7M | $70.9M | ||
| Q1 24 | $77.8M | $57.1M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $2.1M | — |
| Q4 25 | $161.6M | $938.4M | ||
| Q3 25 | $166.7M | $788.8M | ||
| Q2 25 | $163.7M | $761.8M | ||
| Q1 25 | $167.1M | $741.4M | ||
| Q4 24 | $161.0M | $713.4M | ||
| Q3 24 | $162.6M | $719.9M | ||
| Q2 24 | $156.4M | $674.6M | ||
| Q1 24 | $159.7M | $667.9M |
| Q4 25 | $261.1M | $8.7B | ||
| Q3 25 | $264.8M | $8.5B | ||
| Q2 25 | $254.9M | $8.4B | ||
| Q1 25 | $252.7M | $8.2B | ||
| Q4 24 | $240.9M | $8.1B | ||
| Q3 24 | $245.3M | $8.0B | ||
| Q2 24 | $235.8M | $7.9B | ||
| Q1 24 | $247.3M | $7.8B |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.01× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $9.9M | $38.9M |
| Free Cash FlowOCF − Capex | $7.6M | $31.9M |
| FCF MarginFCF / Revenue | 6.1% | 16.4% |
| Capex IntensityCapex / Revenue | 1.9% | 3.6% |
| Cash ConversionOCF / Net Profit | 2.41× | 0.40× |
| TTM Free Cash FlowTrailing 4 quarters | $28.8M | $105.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $9.9M | $38.9M | ||
| Q3 25 | $18.5M | $34.9M | ||
| Q2 25 | $4.3M | $18.9M | ||
| Q1 25 | $2.6M | $22.2M | ||
| Q4 24 | $12.2M | $95.0M | ||
| Q3 24 | $9.6M | $21.2M | ||
| Q2 24 | $1.3M | $27.3M | ||
| Q1 24 | $2.2M | $23.2M |
| Q4 25 | $7.6M | $31.9M | ||
| Q3 25 | $16.8M | $33.9M | ||
| Q2 25 | $3.0M | $18.3M | ||
| Q1 25 | $1.5M | $20.9M | ||
| Q4 24 | $10.0M | $88.8M | ||
| Q3 24 | $7.9M | $18.9M | ||
| Q2 24 | $-2.0M | $26.3M | ||
| Q1 24 | $-1.5M | $21.9M |
| Q4 25 | 6.1% | 16.4% | ||
| Q3 25 | 13.1% | 38.8% | ||
| Q2 25 | 2.6% | 22.1% | ||
| Q1 25 | 1.3% | 25.5% | ||
| Q4 24 | 8.5% | 115.1% | ||
| Q3 24 | 6.9% | 24.7% | ||
| Q2 24 | -1.9% | 36.2% | ||
| Q1 24 | -1.4% | 30.0% |
| Q4 25 | 1.9% | 3.6% | ||
| Q3 25 | 1.3% | 1.1% | ||
| Q2 25 | 1.2% | 0.8% | ||
| Q1 25 | 1.0% | 1.7% | ||
| Q4 24 | 1.9% | 8.1% | ||
| Q3 24 | 1.5% | 2.9% | ||
| Q2 24 | 3.0% | 1.3% | ||
| Q1 24 | 3.3% | 1.9% |
| Q4 25 | 2.41× | 0.40× | ||
| Q3 25 | 3.46× | 1.47× | ||
| Q2 25 | 0.81× | 0.88× | ||
| Q1 25 | 0.55× | 1.13× | ||
| Q4 24 | — | 4.82× | ||
| Q3 24 | 2.21× | 1.14× | ||
| Q2 24 | 0.97× | 1.74× | ||
| Q1 24 | 0.94× | 1.38× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NATR
| Other | $68.1M | 55% |
| General Health Products | $20.2M | 16% |
| Digestive Products | $13.8M | 11% |
| Cardiovascular Products | $12.1M | 10% |
| Personal Care Products | $4.4M | 4% |
| Immunity Products | $3.1M | 3% |
| Weight Management Products | $2.1M | 2% |
TMP
Segment breakdown not available.
